HEMOPTYSIS IS ASSOCIATED WITH UNDERLYING DISEASE SEVERITY AND IS AN EXPECTED ADVERSE EVENT IN CYSTIC FIBROSIS CLINICAL TRIALS

Thompson V; Kloster M.; Flume P. A.; Bilton D.; Mayer-Hamblett N.

首页> 外文期刊>Pediatric Pulmonology >HEMOPTYSIS IS ASSOCIATED WITH UNDERLYING DISEASE SEVERITY AND IS AN EXPECTED ADVERSE EVENT IN CYSTIC FIBROSIS CLINICAL TRIALS

【24h】

HEMOPTYSIS IS ASSOCIATED WITH UNDERLYING DISEASE SEVERITY AND IS AN EXPECTED ADVERSE EVENT IN CYSTIC FIBROSIS CLINICAL TRIALS

机译：咯血与潜在疾病的严重程度有关，是囊性纤维化临床试验中预期的不良事件

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric Pulmonology》 |2014年第38期|共2页
作者
Thompson V; Kloster M.; Flume P. A.; Bilton D.; Mayer-Hamblett N.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. HEMOPTYSIS IS ASSOCIATED WITH UNDERLYING DISEASE SEVERITY AND IS AN EXPECTED ADVERSE EVENT IN CYSTIC FIBROSIS CLINICAL TRIALS [J] . Thompson V, Kloster M., Flume P. A., Pediatric Pulmonology . 2014,第Suppla38期

机译：咯血与潜在疾病的严重程度有关，是囊性纤维化临床试验中预期的不良事件
2. Evaluation of Underlying Cause of Genitourinary (GU) Adverse Events (AEs) in Patients with Myelodysplastic Syndromes upon Oral Administration of Rigosertib: Safety and Pharmacokinetic Analysis of Rigosertib across Three Clinical Trials [J] . Maniar Manoj, Ren Chen, Zbyszewski Patrick S., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：霉菌（GU）泌尿病患者患者脊髓细胞增强症患者潜在原因的评价：严格鉴定的安全性和药代动力学分析三种临床试验中的RIGOSERTIB
3. Respiratory adverse event profiles in cystic fibrosis placebo subjects in short- and long-term inhaled therapy trials. [J] . Sucharew H, Goss CH, Millard SP, Contemporary clinical trials . 2006,第6期

机译：在短期和长期吸入治疗试验中，囊性纤维化安慰剂受试者的呼吸不良事件特征。
4. BREATH ANALYSIS WITH SECONDARY IONIZATION HIGH-RESOLUTION MASS SPECTROMETRY (SESI-HRMS) IN THE CLINICAL ENVIRONMENT WITH A FOCUS ON DISEASE SPECIFIC BIOMARKERS IN CHILDREN WITH CYSTIC FIBROSIS [C] . Tobias Bruderer, Naemi Haas-Baumann, Ronja Weber, International Mass Spectrometry Conference . 2018

机译：临床环境中二次电离高分辨率质谱（SESI-HRMS）对患有囊性纤维化的儿童疾病特异性生物标志物的呼吸分析
5. Quantifying disease severity of cystic fibrosis using linear quantile mixed models. [D] . Denaro, Kameryn R. 2016

机译：使用线性分位数混合模型量化囊性纤维化的疾病严重程度。
6. RISK OF HEMOPTYSIS IN CYSTIC FIBROSIS CLINICAL TRIALS: A RETROSPECTIVE COHORT STUDY [O] . Ms. V. Thompson, Dr. N. Mayer-Hamblett, Ms. M. Kloster, -1

机译：囊性纤维化临床试验中咯血的风险：回顾性队列研究
7. Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: results from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) Registry T.C.VillinesE.A.HultenL.J.ShawPrevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: results from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) RegistryJam. Coll. Cardiol.572011 April 5E2035 [O] . Christopher Johann 2012

机译：有症状的冠状动脉钙化评分为零的有症状患者接受冠状动脉计算机断层摄影血管造影术时，冠状动脉疾病的患病率和严重性及其不良事件：来自CONFIRM（临床结果的冠状CT血管造影评估：国际多中心）注册机构TCVillinesE.A.HultenL J.Shaw冠状动脉钙化评分为零的有症状患者接受冠状动脉计算机断层摄影血管造影的冠状动脉疾病患病率和严重性以及不良事件：来自CONFIRM（临床结果的冠状CT血管造影评估：国际多中心）RegistryJam的结果。 Coll。 Cardiol.572011 4月5E2035

HEMOPTYSIS IS ASSOCIATED WITH UNDERLYING DISEASE SEVERITY AND IS AN EXPECTED ADVERSE EVENT IN CYSTIC FIBROSIS CLINICAL TRIALS

著录项

相似文献

相关主题

期刊订阅